Cargando…
An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching
Although TGF-β signaling can effectively activate fibroblasts to transform to myofibroblasts, the underlying mechanisms involved in the cell fate switching for trans-differentiation have not been fully elucidated. In this study, we found the evidence of an intermediate state in the process of trans-...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441076/ https://www.ncbi.nlm.nih.gov/pubmed/34541470 http://dx.doi.org/10.1016/j.isci.2021.103057 |
_version_ | 1783752802487500800 |
---|---|
author | Ye, Zhikai Li, Wenbo Jiang, Zhenlong Wang, Erkang Wang, Jin |
author_facet | Ye, Zhikai Li, Wenbo Jiang, Zhenlong Wang, Erkang Wang, Jin |
author_sort | Ye, Zhikai |
collection | PubMed |
description | Although TGF-β signaling can effectively activate fibroblasts to transform to myofibroblasts, the underlying mechanisms involved in the cell fate switching for trans-differentiation have not been fully elucidated. In this study, we found the evidence of an intermediate state in the process of trans-differentiation. In the early stage of trans-differentiation, cells enter the intermediate state first with multiple characteristics such as accelerating cell cycle, metabolic switching, enhanced anti-apoptotic ability, and pluripotency, which is very similar to the early stage of reprogramming. As the trans-differentiation continues, these characteristics get switched. Therefore, trans-differentiation appears to require the switching of cell proliferation ability, metabolic pathway, and “stemness” to complete the process. In this study, we can conclude that an intermediate state may be necessary with high pluripotency in trans-differentiation from fibroblasts to myofibroblasts. Only after passing the intermediate state, the trans-differentiation is finally completed and will not easily return to the original state. |
format | Online Article Text |
id | pubmed-8441076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84410762021-09-17 An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching Ye, Zhikai Li, Wenbo Jiang, Zhenlong Wang, Erkang Wang, Jin iScience Article Although TGF-β signaling can effectively activate fibroblasts to transform to myofibroblasts, the underlying mechanisms involved in the cell fate switching for trans-differentiation have not been fully elucidated. In this study, we found the evidence of an intermediate state in the process of trans-differentiation. In the early stage of trans-differentiation, cells enter the intermediate state first with multiple characteristics such as accelerating cell cycle, metabolic switching, enhanced anti-apoptotic ability, and pluripotency, which is very similar to the early stage of reprogramming. As the trans-differentiation continues, these characteristics get switched. Therefore, trans-differentiation appears to require the switching of cell proliferation ability, metabolic pathway, and “stemness” to complete the process. In this study, we can conclude that an intermediate state may be necessary with high pluripotency in trans-differentiation from fibroblasts to myofibroblasts. Only after passing the intermediate state, the trans-differentiation is finally completed and will not easily return to the original state. Elsevier 2021-08-28 /pmc/articles/PMC8441076/ /pubmed/34541470 http://dx.doi.org/10.1016/j.isci.2021.103057 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Ye, Zhikai Li, Wenbo Jiang, Zhenlong Wang, Erkang Wang, Jin An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching |
title | An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching |
title_full | An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching |
title_fullStr | An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching |
title_full_unstemmed | An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching |
title_short | An intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching |
title_sort | intermediate state in trans-differentiation with proliferation, metabolic, and epigenetic switching |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441076/ https://www.ncbi.nlm.nih.gov/pubmed/34541470 http://dx.doi.org/10.1016/j.isci.2021.103057 |
work_keys_str_mv | AT yezhikai anintermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching AT liwenbo anintermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching AT jiangzhenlong anintermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching AT wangerkang anintermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching AT wangjin anintermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching AT yezhikai intermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching AT liwenbo intermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching AT jiangzhenlong intermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching AT wangerkang intermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching AT wangjin intermediatestateintransdifferentiationwithproliferationmetabolicandepigeneticswitching |